HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tuomas Tammela Selected Research

Vascular Endothelial Growth Factor C

6/2015Growth factor therapy and lymph node graft for lymphedema.
9/2014The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
8/2013Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization.
4/2011Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis.
2/2011Growth factor therapy and autologous lymph node transfer in lymphedema.
5/2009Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism.
4/2009VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
6/2007Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
9/2006Vascular endothelial growth factor-C accelerates diabetic wound healing.
2/2005The biology of vascular endothelial growth factors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tuomas Tammela Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 02/2005
7Neoplasm Metastasis (Metastasis)
01/2019 - 12/2007
5Edema (Dropsy)
08/2013 - 09/2002
5Inflammation (Inflammations)
08/2013 - 02/2005
4Lymphedema (Milroy Disease)
06/2015 - 09/2002
3Adenoma (Adenomas)
01/2021 - 01/2017
3Adenocarcinoma of Lung
01/2020 - 08/2014
3Lung Neoplasms (Lung Cancer)
01/2020 - 08/2014
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2017
3Hyperplasia
05/2009 - 06/2005
3Wounds and Injuries (Trauma)
07/2008 - 11/2004
2Infections
02/2011 - 02/2005
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2010 - 02/2005
1Adenocarcinoma
12/2020
1Pneumonia (Pneumonitis)
01/2020
1Carcinoma (Carcinomatosis)
01/2018
1Breast Neoplasms (Breast Cancer)
06/2015
1Glaucoma
09/2014
1Sarcoma (Soft Tissue Sarcoma)
08/2014
1Hemangioma (Angioma)
01/2013
1Contact Dermatitis (Eczema, Contact)
04/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2011
1Seroma
02/2011
1Cardiomegaly (Heart Hypertrophy)
10/2010
1Hypertrophy
10/2010
1Hypertension (High Blood Pressure)
05/2009
1Pathologic Neovascularization
04/2009
1Ischemia
05/2007
1Respiratory Tract Infections (Respiratory Tract Infection)
02/2005

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2017 - 09/2002
12Vascular Endothelial Growth Factor CIBA
06/2015 - 09/2002
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2015 - 02/2005
6Vascular Endothelial Growth Factor DIBA
02/2011 - 09/2002
5LigandsIBA
01/2017 - 04/2009
4Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
06/2015 - 07/2008
3Pharmaceutical PreparationsIBA
12/2020 - 11/2018
3Vascular Endothelial Growth Factor BIBA
10/2010 - 02/2005
2RNA (Ribonucleic Acid)IBA
01/2021 - 08/2014
2Therapeutic UsesIBA
06/2015 - 02/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2015 - 04/2009
2Placenta Growth FactorIBA
08/2013 - 10/2010
2AntibodiesIBA
03/2012 - 12/2010
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2009 - 02/2005
1PlasticsIBA
01/2022
1Biological ProductsIBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1Metalloproteases (Metalloproteinases)IBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1LGK974IBA
11/2018
1Cre recombinaseIBA
01/2018
1Capsules (Microcapsules)IBA
01/2018
1Recombinant ProteinsIBA
04/2017
1Neoplasm Antigens (Tumor Antigens)IBA
09/2015
1CRISPR-Associated ProteinsIBA
10/2014
1MicroRNAs (MicroRNA)IBA
08/2014
1Small Interfering RNA (siRNA)IBA
08/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2013
1GlucocorticoidsIBA
04/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2012
1TIE-2 Receptor (Receptor, TIE 2)IBA
03/2012
1Angiopoietin-2IBA
03/2012
1Vascular Endothelial Growth FactorsIBA
12/2010
1Blocking AntibodiesIBA
12/2010
1Protein Isoforms (Isoforms)IBA
10/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2010
1Neuropilin-1IBA
10/2010
1human VEGFB proteinIBA
10/2010
1SaltsIBA
05/2009
1Angiopoietin-1IBA
06/2005
1Anti-Bacterial Agents (Antibiotics)IBA
02/2005

Therapy/Procedure

12Therapeutics
01/2022 - 06/2005
4Transplantation
01/2018 - 12/2007
3Radiotherapy
06/2015 - 12/2007
1Intravenous Injections
03/2012
1Photochemotherapy (Photodynamic Therapy)
02/2011